tiprankstipranks
Mural Oncology Plc (MURA)
NASDAQ:MURA
US Market

Mural Oncology Plc (MURA) Financial Statements

15 Followers

Mural Oncology Plc Financial Overview

Mural Oncology Plc's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Mural Oncology Plc is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-1.95. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23
Income Statement-
Total Revenue-
Gross Profit-
EBIT$ -195.29M
EBITDA$ -192.69M
Net Income Common Stockholders$ -207.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 270.85M
Total Assets$ 301.75M
Total Debt$ 15.01M
Net Debt$ -255.84M
Total Liabilities$ 37.93M
Stockholders Equity$ 263.82M
Cash Flow-
Free Cash Flow$ -197.70M
Operating Cash Flow$ -194.25M
Investing Cash Flow$ -3.45M
Financing Cash Flow$ 468.81M
Currency in USD

Mural Oncology Plc Earnings and Revenue History

Mural Oncology Plc Debt to Assets

Mural Oncology Plc Cash Flow

Mural Oncology Plc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis